Yes‑associated protein expression is associated with poor prognosis in patients with colorectal cancer

Cao,Liyu; Zhang,Cong; Wu,Qingqing; Bai,Zhenzhen; Chen,Jing

doi:10.3892/ol.2021.12903

Yes‑associated protein expression is associated with poor prognosis in patients with colorectal cancer

Authors:
- Liyu Cao
- Cong Zhang
- Qingqing Wu
- Zhenzhen Bai
- Jing Chen
View Affiliations

Affiliations: Department of Pathology, Fuyang Hospital of Anhui Medical University, Fuyang, Anhui 236000, P.R. China
Published online on: July 7, 2021 https://doi.org/10.3892/ol.2021.12903
Article Number: 642
Copyright: © Cao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Colorectal cancer (CRC) is the third leading cause of cancer‑related death worldwide. The aim of the present study was to investigate the expression of yes‑associated protein (YAP) in CRC tissues, and to determine the relationship between the expression levels of YAP and the clinicopathological characteristics and prognosis of patients with CRC. Bioinformatics analysis was conducted to examine the expression of YAP and its correlation with clinicopathological characteristics and key genes, using functional enrichment analysis. Immunohistochemistry was used to detect YAP expression in 181 CRC tissue samples and 30 normal colorectal mucosa samples. Western blotting and reverse transcription‑quantitative PCR were performed to detect the expression of YAP and β‑catenin in CRC cells, and cellular proliferation was assessed using a Cell Counting Kit‑8 assay. Finally, apoptosis was analyzed using flow cytometry. Immunohistochemical staining indicated that the positive expression rate of YAP in CRC tissues was 73.5%, which was significantly higher than that in normal colorectal mucosa samples. The expression of YAP in CRC was associated with histological differentiation, lymph node metastasis and Duke's stage. However, no significant associations were observed between YAP expression and age, sex and T stage. Downregulation of YAP promoted the proliferation and the inhibited apoptosis of CRC cells, and YAP expression was positively correlated with that of β‑catenin in both CRC tissues and cells. Furthermore, YAP expression was upregulated in CRC tissues, which was correlated with tumor progression and prognosis. Therefore, YAP expression may be used as an independent predictor of poor prognosis in patients with CRC, and the underling molecular mechanism may be associated with the combined effect of Hippo and Wnt/β‑catenin signaling.

View Figures

View References

1	DeSantis CE, Miller KD, Dale W, Mohile SG, Cohen HJ, Leach CR, Goding Sauer A, Jemal A and Siegel RL: Cancer statistics for adults aged 85 years and older, 2019. CA Cancer J Clin. 69:452–467. 2019. View Article : Google Scholar : PubMed/NCBI
2	Siegel RL, Miller KD, Goding Sauer A, Fedewa SA, Butterly LF, Anderson JC, Cercek A, Smith RA and Jemal A: Colorectal cancer statistics, 2020. CA Cancer J Clin. 70:145–164. 2020. View Article : Google Scholar : PubMed/NCBI
3	Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
4	Garza Treviño EN, González PD, Valencia Salgado CI and Martinez Garza A: Effects of pericytes and colon cancer stem cells in the tumor microenvironment. Cancer Cell Int. 19:1732019. View Article : Google Scholar
5	Tang M, Wang H, Cao Y, Zeng Z, Shan X and Wang L: Nomogram for predicting occurrence and prognosis of liver metastasis in colorectal cancer: A population-based study. Int J Colorectal Dis. 36:271–282. 2021. View Article : Google Scholar : PubMed/NCBI
6	Zanconato F, Cordenonsi M and Piccolo S: YAP and TAZ: A signalling hub of the tumour microenvironment. Nat Rev Cancer. 19:454–464. 2019. View Article : Google Scholar : PubMed/NCBI
7	Yang R, Cai TT, Wu XJ, Liu YN, He J, Zhang XS, Ma G and Li J: Tumour YAP1 and PTEN expression correlates with tumour-associated myeloid suppressor cell expansion and reduced survival in colorectal cancer. Immunology. 155:263–272. 2018. View Article : Google Scholar : PubMed/NCBI
8	Pan Y, Tong JHM, Lung RWM, Kang W, Kwan JSH, Chak WP, Tin KY, Chung LY, Wu F, Ng SSM, et al: RASAL2 promotes tumor progression through LATS2/YAP1 axis of hippo signaling pathway in colorectal cancer. Mol Cancer. 17:1022018. View Article : Google Scholar : PubMed/NCBI
9	Moon S, Kim W, Kim S, Kim Y, Song Y, Bilousov O, Kim J, Lee T, Cha B, Kim M, et al: Phosphorylation by NLK inhibits YAP-14-3-3-interactions and induces its nuclear localization. EMBO Rep. 18:61–71. 2017. View Article : Google Scholar : PubMed/NCBI
10	Felley-Bosco E and Stahel R: Hippo/YAP pathway for targeted therapy. Transl Lung Cancer Res. 3:75–83. 2014.PubMed/NCBI
11	Tsuji T, Ozasa H, Aoki W, Aburaya S, Yamamoto Funazo T, Furugaki K, Yoshimura Y, Yamazoe M, Ajimizu H, Yasuda Y, et al: YAP1 mediates survival of ALK-rearranged lung cancer cells treated with alectinib via pro-apoptotic protein regulation. Nat Commun. 11:742020. View Article : Google Scholar : PubMed/NCBI
12	Yu S, Zhang Y, Li Q, Zhang Z, Zhao G and Xu J: CLDN6 promotes tumor progression through the YAP1-snail1 axis in gastric cancer. Cell Death Dis. 10:9492019. View Article : Google Scholar : PubMed/NCBI
13	Yan H, Li H, Li P, Li X, Lin J, Zhu L, Silva MA, Wang X, Wang P and Zhang Z: Long noncoding RNA MLK7-AS1 promotes ovarian cancer cells progression by modulating miR-375/YAP1 axis. J Exp Clin Cancer Res. 37:2372018. View Article : Google Scholar : PubMed/NCBI
14	Guo L, Chen Y, Luo J, Zheng J and Shao G: YAP1 overexpression is associated with poor prognosis of breast cancer patients and induces breast cancer cell growth by inhibiting PTEN. FEBS Open Bio. 9:437–445. 2019. View Article : Google Scholar : PubMed/NCBI
15	Yin MX and Zhang L: Hippo signaling in epithelial stem cells. Acta Biochim Biophys Sin (Shanghai). 47:39–45. 2015. View Article : Google Scholar : PubMed/NCBI
16	Park J, Kim GH, Lee J, Phuong BTC, Kong B, Won JE, Won GW, Lee YH, Han HD and Lee Y: MST2 silencing induces apoptosis and inhibits tumor growth for estrogen receptor alpha-positive MCF-7 breast cancer. Toxicol Appl Pharmacol. 408:1152572020. View Article : Google Scholar : PubMed/NCBI
17	Hasegawa K, Fujii S, Matsumoto S, Tajiri Y, Kikuchi A and Kiyoshima T: YAP signaling induces PIEZO1 to promote oral squamous cell carcinoma cell proliferation. J Pathol. 253:80–93. 2021. View Article : Google Scholar : PubMed/NCBI
18	Liu Y, Wang X and Yang Y: Hepatic Hippo signaling inhibits development of hepatocellular carcinoma. Clin Mol Hepatol. 26:742–750. 2020. View Article : Google Scholar : PubMed/NCBI
19	Azar WJ, Christie EL, Mitchell C, Liu DS, Au-Yeung G and Bowtell DDL: Noncanonical IL6 signaling-mediated activation of YAP regulates cell migration and invasion in ovarian clear cell cancer. Cancer Res. 80:4960–4971. 2020. View Article : Google Scholar : PubMed/NCBI
20	Dey A, Varelas X and Guan KL: Targeting the Hippo pathway in cancer, fibrosis, wound healing and regenerative medicine. Nat Rev Drug Discov. 19:480–494. 2020. View Article : Google Scholar : PubMed/NCBI
21	Ma K, Xu Q, Wang S, Zhang W, Liu M, Liang S, Zhu H and Xu N: Nuclear accumulation of Yes-associated protein (YAP) maintains the survival of doxorubicin-induced senescent cells by promoting survivin expression. Cancer Lett. 375:84–91. 2016. View Article : Google Scholar : PubMed/NCBI
22	Kriz V and Korinek V: Wnt, RSPO and Hippo signalling in the intestine and intestinal stem cells. Genes (Basel). 9:202018. View Article : Google Scholar : PubMed/NCBI
23	Kahn M: Can we safely target the WNT pathway? Nat Rev Drug Discov. 13:513–532. 2014. View Article : Google Scholar : PubMed/NCBI
24	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
25	Camargo FD, Gokhale S, Johnnidis JB, Fu D, Bell GW, Jaenisch R and Brummelkamp TR: YAP1 increases organ size and expands undifferentiated progenitor cells. Curr Biol. 17:2054–2060. 2007. View Article : Google Scholar : PubMed/NCBI
26	Zhou D, Zhang Y, Wu H, Barry E, Yin Y, Lawrence E, Dawson D, Willis JE, Markowitz SD, Camargo FD and Avruch J: Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance. Proc Natl Acad Sci USA. 108:E1312–E1320. 2011. View Article : Google Scholar : PubMed/NCBI
27	Li H, Wang S, Wang G, Zhang Z, Wu X, Zhang T, Fu B and Chen G: Yes-associated protein expression is a predictive marker for recurrence of hepatocellular carcinoma after liver transplantation. Dig Surg. 31:468–478. 2014. View Article : Google Scholar : PubMed/NCBI
28	van Bree C, Franken NA, Snel FA, Haveman J and Bakker PJ: Wild-type p53-function is not required for hyperthermia-enhanced cytotoxicity of cisplatin. Int J Hyperthermia. 17:337–346. 2001. View Article : Google Scholar : PubMed/NCBI
29	Nagashima M, Shiseki M, Pedeux RM, Okamura S, Kitahama-Shiseki M, Miura K, Yokota J and Harris CC: A novel PHD-finger motif protein, p47ING3, modulates p53-mediated transcription, cell cycle control, and apoptosis. Oncogene. 22:343–350. 2003. View Article : Google Scholar : PubMed/NCBI